The announcement of Dewpoint Therapeutics $100M partnership Bayer to research new treatments for cardiovascular and gynecological diseases has received significant media attention. A selection of key coverage and analysis can be found via the links below.
Read more on nature.com
Read more on fiercebiotech.com
Read more on xconomy.com
Read more on endpts.com
Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science